Lonza says its US-based sites are in high demand as pharma tariffs near
Lonza said on Friday it does not expect any “material financial impact” from current and potential pharma-specific tariffs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
